Cargando…

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients

INTRODUCTION: Identifying patients at high risk of developing kidney disease could lead to early clinical interventions that prevent or slow disease progression. Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker thought to be involved in the pathogenesis and devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iversen, Esben, Houlind, Morten Baltzer, Kallemose, Thomas, Rasmussen, Line Jee Hartmann, Hornum, Mads, Feldt-Rasmussen, Bo, Hayek, Salim S., Andersen, Ove, Eugen-Olsen, Jesper
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303513/ https://www.ncbi.nlm.nih.gov/pubmed/32596235 http://dx.doi.org/10.3389/fcell.2020.00339

Ejemplares similares

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department
por: Walls, Anne Byriel, et al.
Publicado: (2021)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease
por: Iversen, Esben, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial
por: Schultz, Martin, et al.
Publicado: (2019)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2016)

Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]
por: Houlind, Morten Baltzer, et al.
Publicado: (2022)

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2017)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy
por: Schultz, Martin, et al.
Publicado: (2019)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
por: Meyer, Jeppe, et al.
Publicado: (2018)

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2020)

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)
por: Schultz, Martin, et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis
por: Petersen, Jens Emil Vang, et al.
Publicado: (2020)

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*
por: Rasmussen, Line J. H., et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

Stressful Life Events and Inflammation in Midlife: Comparing Associations With suPAR, CRP, and IL-6
por: Bourassa, Kyle, et al.
Publicado: (2020)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Estimating Renal Function Following Lung Transplantation
por: Hornum, Mads, et al.
Publicado: (2022)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

Assay-related differences in SuPAR levels: implications for measurement and data interpretation
por: Vasbinder, Alexi, et al.
Publicado: (2022)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department
por: Santeri, Seppälä, et al.
Publicado: (2021)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controls
por: Langkilde, Anne, et al.
Publicado: (2015)

suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
por: Haupt, Thomas Huneck, et al.
Publicado: (2012)

SuPAR mediates viral response proteinuria by rapidly changing podocyte function
por: Wei, Changli, et al.
Publicado: (2023)

suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
por: Nusshag, Christian, et al.
Publicado: (2023)

Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery
por: Rasmussen, Sebastian Roed, et al.
Publicado: (2021)

suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sv9b1adlee3k1dfakbekk65nvm